Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
37.00
-1.30 (-3.39%)
Oct 3, 2025, 5:04 PM CET
-3.39%
Market Cap679.15M
Revenue (ttm)373.90M
Net Income (ttm)465.00K
Shares Out18.36M
EPS (ttm)0.03
PE Ratio1,460.54
Forward PE224.24
Dividendn/a
Ex-Dividend Daten/a
Volume23,209
Average Volume49,335
Open38.30
Previous Close38.30
Day's Range36.90 - 38.50
52-Week Range26.50 - 62.40
Beta0.07
RSI56.96
Earnings DateSep 12, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.